| ACNB | 8-K | bullish | 6/10 | ACNB Corporation reported record Q3 2026 net income of $15.7 million, or $1.55 diluted EPS, beating the $1.41 consensus | Oct 22, 2026 |
| SPH | 8-K | bullish | 4/10 | Suburban Propane Partners declared a quarterly distribution increase from $0.325 to $0.35 per common unit, raising the a | Oct 22, 2026 |
| VBIO | 8-K | neutral | 4/10 | Valion Bio's interim CEO Dean Zikria released a 30-day strategic review outlining three priorities: advancing the Entoli | Oct 22, 2026 |
| MIRA | 8-K | bullish | 5/10 | MIRA Pharmaceuticals reported positive preclinical results for MIRA-55, an oral synthetic cannabinoid analog for chronic | Oct 22, 2026 |
| QIND | 8-K | neutral | 4/10 | QIND announced an amendment to its Al Shola Gas purchase agreement, restructuring the remaining $6.98 million of the $10 | Oct 22, 2026 |
| UBSI | 8-K | neutral | 5/10 | United Bankshares reported Q3 2026 diluted EPS of $0.94, in line with the $0.94 consensus, on net income of $128.7 milli | Oct 22, 2026 |
| UNP | 8-K | bullish | 6/10 | Union Pacific reported Q3 2026 GAAP diluted EPS of $3.49 (adjusted $3.53), beating consensus of $3.29 by 7.3%, on operat | Oct 22, 2026 |
| COCO | 8-K | bullish | 6/10 | Vita Coco reported Q3 2026 net sales of $244M (+34% YoY) and diluted EPS of $0.58, beating the $0.53 consensus. The comp | Oct 22, 2026 |
| TCX | 8-K | bullish | 6/10 | Tucows' Ting Fiber subsidiary has entered into an agreement to transfer its dark fiber network lease in Colorado Springs | Oct 22, 2026 |
| ABUS | 8-K | bullish | 6/10 | Arbutus Biopharma announced that the FDA has lifted the clinical hold on the IND for AB-101, its oral PD-L1 inhibitor fo | Oct 22, 2026 |
| CNOB | 8-K | mixed | 6/10 | ConnectOne Bancorp reported Q3 2026 operating EPS of $0.95, a 9.2% beat vs $0.87 consensus, driven by accelerating net i | Oct 22, 2026 |
| LSCC | 8-K | neutral | 2/10 | Lattice Semiconductor appointed John McCool and Raejeanne Skillern to its Board of Directors, expanding the board from 8 | Oct 22, 2026 |
| STBA | 8-K | bullish | 6/10 | S&T Bancorp reported record Q3 2026 diluted EPS of $1.09, in line with consensus, on net income of $38.6M (+10.4% YoY). | Oct 22, 2026 |
| LNTH | 8-K | neutral | 5/10 | Lantheus disclosed that it and acquirer Curium US Holdings each received a Second Request from the FTC on October 21, 20 | Oct 22, 2026 |
| PHM | 8-K | bearish | 6/10 | PulteGroup reported Q3 2026 EPS of $2.53, slightly below consensus of $2.54, on home sale revenues of $3.86B, which miss | Oct 22, 2026 |
| TSCO | 8-K | mixed | 5/10 | Tractor Supply reported Q3 2026 EPS of $0.43, beating consensus of $0.40 by 7.5%, on revenue of $3.91B (5.1% YoY growth, | Oct 22, 2026 |
| NDAQ | 8-K | mixed | 5/10 | Nasdaq reported Q3 2026 net revenue of $1.481B (+13% YoY) and GAAP diluted EPS of $0.96 (+31% YoY), while non-GAAP dilut | Oct 22, 2026 |
| EDBL | 8-K | neutral | 3/10 | Edible Garden AG entered into a 2-year produce supply agreement with Caney Fork Farms, LLC for year-round supply of fres | Oct 22, 2026 |
| CIVB | 8-K | bullish | 6/10 | Civista Bancshares reported Q3 2026 net income of $16.0M ($0.77 diluted EPS), a 25.5% YoY increase from $12.8M ($0.68). | Oct 22, 2026 |
| SGMT | 8-K | neutral | 4/10 | Sagimet Biosciences filed an 8-K with an updated investor presentation on October 22, 2026. The presentation highlights | Oct 22, 2026 |
| MSM | 8-K | bullish | 6/10 | MSC Industrial reported fiscal Q4 2026 adjusted diluted EPS of $1.45, beating consensus of $1.24 by 16.9%, on record net | Oct 22, 2026 |
| VLY | 8-K | bullish | 6/10 | Valley National Bancorp reported Q3 2026 net income of $206.3M ($0.36 diluted EPS), a record quarterly result, driven by | Oct 22, 2026 |
| CMCSA | 8-K | mixed | 5/10 | Comcast reported Q3 2026 adjusted EPS of $1.07, beating consensus of $0.98 by 9.2%, but total revenue declined 6.1% YoY | Oct 22, 2026 |
| VFF | 8-K | neutral | 2/10 | Village Farms International filed an 8-K announcing that it will release Q3 2026 financial results on November 9, 2026, | Oct 22, 2026 |
| KRRO | 8-K | bullish | 6/10 | Korro Bio reported preclinical data for KRRO-111, its RNA-editing candidate for Alpha-1 Antitrypsin Deficiency (AATD), s | Oct 22, 2026 |
| VC | 8-K | bearish | 6/10 | Visteon reported Q3 2026 net sales of $970M (+6% YoY) and net income of $5M ($0.19/diluted share), compared to a net los | Oct 22, 2026 |
| CBRE | 8-K | bullish | 6/10 | CBRE reported Q3 2026 Core EPS of $2.05, up 28% YoY, on revenue of $11.5 billion (+13% YoY). Both resilient and transact | Oct 22, 2026 |
| ROP | 8-K | neutral | 5/10 | Roper Technologies reported Q3 2026 adjusted DEPS of $5.89, slightly below the consensus estimate of $5.91, on revenue o | Oct 22, 2026 |
| PG | 8-K | neutral | 5/10 | PG reported fiscal Q1 2027 results with net sales of $23.3B (+4% YoY) and diluted EPS of $1.97 (+1% YoY), both above con | Oct 22, 2026 |
| GUTS | 8-K | mixed | 6/10 | Fractyl Health is restructuring to focus entirely on its Revita device for post-GLP-1 weight maintenance after positive | Oct 22, 2026 |